Participants 64 123 6
patients with mild-to-moderately-active ulcerative colitis:
Participants 447 676 6
multicenter study patients with symptoms of acute UC and a baseline Modified Mayo Disease Activity Index (MMDAI) score between 6 and 10, inclusive, with a subscale rating of > or =2 for both rectal bleeding and mucosal appearance
Participants 1053 1106 6
A total of 249 patients (166 balsalazide, 83 placebo)
Participants 1896 1919 3
patients with active UC
